SCHEMBL19006847

SCHEMBL19006847

Cn1c(=O)c2c(ncn2Cc2ccc(OCc3ccccc3)c(OCc3ccccc3)c2)n(Cc2ccc(OCc3ccccc3)c(OCc3ccccc3)c2)c1=O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE1A P54750 1/20 0.60
PDE1B Q01064 1/20 0.60
PDE1C Q14123 1/20 0.60
SMN1; SMN2 Q16637 5/20 0.58
RXFP1 Q9HBX9 2/20 0.58
ADORA2B P29275 1/20 0.58
POLB P06746 1/20 0.53
HIF1A Q16665 1/20 0.53
TP53 P04637 1/20 0.53
HTT P42858 2/20 0.53
UBE2N P61088 2/20 0.53
GLA P06280 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
LMNA P02545 2/20 0.51
CASP1 P29466 1/20 0.50
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
ALDH1A1 P00352 2/20 0.49
MAPK1 P28482 1/20 0.49
CNOT7 Q9UIV1 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15869891 0.94 PDE1A (0.54) PDE1APDE1BPDE1CSMN1; SMN2RXFP1
SCHEMBL15869889 0.87 HIF1A (0.56) PDE1APDE1BPDE1CSMN1; SMN2RXFP1
SCHEMBL556216 0.84 SMN1; SMN2 (0.80) PDE1APDE1BPDE1CSMN1; SMN2RXFP1
SCHEMBL15870738 0.84 ADORA2A (0.54) PDE1APDE1BPDE1CSMN1; SMN2RXFP1
SCHEMBL19006914 0.83 MAPK1 (0.53) ADORA2BL3MBTL1LMNAMEN1KMT2A
SCHEMBL555839 0.81 PDE1A (0.67) PDE1APDE1BPDE1CSMN1; SMN2RXFP1
SCHEMBL15862281 0.79 ALDH1A1 (0.67) SMN1; SMN2HIF1ATP53HTTL3MBTL1
SCHEMBL555718 0.78 SMN1; SMN2 (0.76) PDE1APDE1BPDE1CSMN1; SMN2RXFP1
SCHEMBL14907910 0.77 SMN1; SMN2 (0.58) PDE1APDE1BPDE1CSMN1; SMN2RXFP1
Hydrochloric Acid SCHEMBL11532235 0.77 ALDH1A1 (0.57) SMN1; SMN2RXFP1ADORA2BPOLBHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2753333-B1 CAFFEINATED COMPOUNDS AND COMPOSITIONS FOR TREATMENT OF AMYLOID DISEASES AND SYNUCLEINOPATHIES PROTAMED INC (US) 2017-06-21 EP disclosed